Anti-inflammatory properties of macrolide antibiotics

Journal of Pharmacy Practice

Volumn 19, Issue 5, 2006, Pages 326-329

  Kourlas, Helen ^a,b  

^a LONG ISLAND UNIVERSITY   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

Azithromycin; Clarithromycin; Erythromycin; Inflammation; Lung diseases; Macrolide

Indexed keywords

AZITHROMYCIN; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; BUDESONIDE; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; METHACHOLINE; METHYLPREDNISOLONE; SALMETEROL; TROLEANDOMYCIN;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIOSTASIS; BRONCHIECTASIS; BRONCHITIS; CHLAMYDIA; CHRONIC BRONCHITIS; CHRONIC INFLAMMATION; CYSTIC FIBROSIS; DRUG MECHANISM; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; LEGIONELLA; LIVER TOXICITY; LUNG DISEASE; MEDLINE; MUCUS SECRETION; MYCOPLASMA; RESPIRATORY TRACT DISEASE; REVIEW; TREATMENT OUTCOME;

EID: 34248159890     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190006295800     Document Type: Review

References (10)

1. Tamaoki J., Kadota J., Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004 ; 117 ; 5S - 11S.
2. Tamaoki J. The effects of macrolides on inflammatory cells. Chest. 2004 ; 125 ; 41S - 51S.
3. Ianaro A., Ialenti A., Maffia P., et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther. 2000 ; 292: 156-163.
4. Micromedex Health Series [Internet database]. Greenwood Village, Colo: Thomson Micromedex. Accessed September 6, 2006.
5. Scaglione F., Rossoni G. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J Antimicrob Chemother. 1998 ; 41 (suppl lB). 47-50.
6. Zeiger RS, Schatz M., Sperling W. Efficacy of troleandomycin in outpatients with severe, corticosteriod-dependent asthma. J Allergy Clin Immunol. 1980 ; 66 ; 6: 438-446.
7. Kadota J., Sakito O., Kohno S., et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1993 ; 147: 153-159.
8. Tamaoki J., Takeyama K., Tagaya E., Kimio K. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother. 1995 ; 36 ; 8: 1688-1690.
9. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB Maintenance azithromycin therapy for bronchiolitis obliterans syndromes. Am J Respir Crit Care Med. 2003 ; 168: 121-125.
10. Kostadima E., Tsiodras S., Alexopoulos EI, et al. Clarithromycin reduced the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J. 2004 ; 23: 714-717.